DNA damage is a novel response to sublytic complement CSb-9-induced injury in podocytes

被引:123
作者
Pippin, JW [1 ]
Durvasula, R [1 ]
Petermann, A [1 ]
Hiromura, K [1 ]
Couser, WG [1 ]
Shankland, SJ [1 ]
机构
[1] Univ Washington, Div Nephrol, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1172/JCI200315645
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In response to Ab-complement-mediated injury, podocytes can undergo lysis, apoptosis, or, when exposed to sublytic (<5% lysis) amounts of C5b-9, become activated. Following the insertion of sublytic quantities of C5b-9, there is an increase in signaling pathways and growth factor synthesis and release of proteases, oxidants, and other molecules. Despite an increase in DNA synthesis, however, sublytic C5b-9 is associated with a delay in G(2)/M phase progression in podocytes. Here we induced sublytic C5b-9 injury in vitro by exposing cultured rat podocytes or differentiated postmitotic mouse podocytes to Ab and a complement source; we also studied the passive Heymann nephritis model of experimental membranous nephropathy in rats. A major finding was that sublytic C5b-9-induced injury caused an increase in DNA damage in podocytes both in vitro and in vivo. This was associated with an increase in protein levels for p53, the CDK inhibitor p21, growth-arrest DNA damage-45 (GADD45), and the checkpoint kinases-1 and -2. Sublytic C5b-9 increased extracellular signal-regulated kinase-1 and -2 (ERK-1 and -2), and inhibiting ERK-1 and -2 reduced the increase in p21 and GADD45 and augmented the DNA damage response to sublytic C5b-9-induced injury. These results show that sublytic C5b-9 induces DNA damage in vitro and in vivo and may explain why podocyte proliferation is limited following immune-mediated injury.
引用
收藏
页码:877 / 885
页数:9
相关论文
共 41 条
  • [1] Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis
    Brandt, J
    Pippin, J
    Schulze, M
    Hansch, GM
    Alpers, CE
    Johnson, RJ
    Gordon, K
    Couser, WG
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (02) : 335 - 343
  • [2] CHEN IT, 1995, ONCOGENE, V11, P1931
  • [3] COUSER WG, 1990, J AM SOC NEPHROL, V1, P13
  • [4] Complement (C5b-9) induces DNA synthesis in rat mesangial cells in vitro
    Couser, WG
    Pippin, JW
    Shankland, SJ
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (03) : 905 - 912
  • [5] COUSER WG, 1988, ANNU REV MED, V39, P517
  • [6] COMPLEMENT C5B-9 ACTIVATES CYTOSOLIC PHOSPHOLIPASE A(2) IN GLOMERULAR EPITHELIAL-CELLS
    CYBULSKY, AV
    MONGE, JC
    PAPILLON, J
    MCTAVISH, AJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 269 (05): : F739 - F749
  • [7] Complement activates phospholipases and protein kinases in glomerular epithelial cells
    Cybulsky, AV
    Papillon, J
    McTavish, AJ
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (02) : 360 - 372
  • [8] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [9] INFUSION OF PLATELET-DERIVED GROWTH-FACTOR OR BASIC FIBROBLAST GROWTH-FACTOR INDUCES SELECTIVE GLOMERULAR MESANGIAL CELL-PROLIFERATION AND MATRIX ACCUMULATION IN RATS
    FLOEGE, J
    ENG, E
    YOUNG, BA
    ALPERS, CE
    BARRETT, TB
    BOWENPOPE, DF
    JOHNSON, RJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2952 - 2962
  • [10] FLOEGE J, 1993, AM J PATHOL, V142, P637